The Citalopram/5‐HTP‐induced Head Shake Syndrome is Correlated to 5‐HT₂ Receptor Affinity and also Influenced by other Transmitters

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1981 • 848 citations

SCH 23390—The first selective dopamine D-1 antagonist

1983 • 738 citations

Two Distinct Central Serotonin Receptors with Different Physiological Functions

1981 • 640 citations

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

1982 • 589 citations

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1980 • 543 citations

A METHOD FOR ASSESSING THE EFFECTS OF DRUGS ON THE CENTRAL ACTIONS OF 5‐HYDROXYTRYPTAMINE

1963 • 375 citations

‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity☆

1977 • 330 citations

Serotonin in biological psychiatry.

1982 • 264 citations

Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat

1983 • 189 citations

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

1977 • 174 citations

Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone

1983 • 163 citations

The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist

1983 • 123 citations

Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.

1983 • 103 citations

Correlations between different measures of antiserotonin activity of drugs

1982 • 100 citations

INDOLEAMINE ANTAGONISTS: RELATIVE POTENCIES AS INHIBITORS OF TRYPTAMINE‐ AND 5‐HYDROXYTRYPTOPHAN‐EVOKED RESPONSES

1974 • 97 citations

The effects of 5-HT uptake- and MAO-inhibitors on l-5-HTP-induced excitation in rats

1980 • 71 citations

Blockade of 5-hydroxytryptamine receptors in the central nervous system by β-adrenoceptor antagonists

1977 • 70 citations

Pharmacological profile of a model for central serotonin receptor activation

1980 • 67 citations

Head twitches induced by LSD and quipazine: Similarities and differences

1980 • 66 citations

Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors

1982 • 65 citations

Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity

1981 • 65 citations

Mescaline‐induced head‐twitches in the rat: An in vivo method to evaluate serotonin S₂ antagonists

1983 • 58 citations

Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans

1983 • 48 citations

Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.

1983 • 42 citations

Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models

1983 • 30 citations

THE PHARMACOLOGICAL BASIS OF THE THERAPEUTIC ACTIVITY OF CLEBOPRIDE AND RELATED SUBSTITUTED BENZAMIDES

1982 • 22 citations

Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice

1972 • 21 citations

The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan.

1978 • 20 citations

Neuroleptic Classification: Implications for Tardive Dyskinesia

2015 • 19 citations

Effect of zotepine on head-twitch induced by L-5-Hydroxytryptophan,mescaline and 2,5-Dimethoxy-4-methylamphetamine in mice and rats.

1983 • 9 citations

The effect of the antihistaminic drugs on the central action of 5-hydroxytryptophan in mice.

1981 • 4 citations